At the end of the reporting period, the total assets of Wantai Biopharmwere CNY 7.047 billion, an increase of 101.13% over the beginning of the period.... Read More >

Olink reported before the opening of the market Monday that its Q4 revenues rose 61 percent. Read More >

A globally renowned expert in autoimmune diseases and systemic lupus erythematosus (SLE) at the University of Houston has identified potential biomarkers for neuropsychiatric symptoms of lupus. ... Read More >

The continuous outbreak of the 2021 epidemic has drawn attention to the issue of upstream raw materials in China's IVD industry. Read More >

Bruker on Friday reported that its fourth quarter revenues were up 9 percent year over year, driven by growth across almost all of the firm's business segments.... Read More >

Along with the development of new therapies, advances in technologies that enable earlier diagnosis of cancer are critical to improve patient outcomes. ... Read More >

On January 30, China Telecom Medical Health Technology Co., Ltd. was established with a registered capital of CNY 200 million. Read More >

Illumina reported after the close of the market on Thursday that its fourth quarter 2021 revenues rose 26 percent year over year, narrowly beating its own forecast last month of 25 percent growth.... Read More >

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced financial results for the fourth quarter and year ended December 31, 2021.... Read More >

Jiangsu Mole Bioscience obtained the approval of the Helicobacter pylori 23S rRNA gene and gyrA gene mutation test kit (fluorescence PCR method) by NMPA. This kit is the first product in China that can simultaneously detect clarithromycin and levofloxacin resistance genes.... Read More >